Impact of natural disasters and infectious diseases on business operations and customers’ IT investment
First written in FY2020. 2 of 6 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2023RestatedAnnual report
「The Company’s Risk Management Committee reviews risks relating to all of its business activities every month. When it determines that investigations or measures concerning disasters, occupational safety or health are necessary, it instructs the Corporate Headquarters to consider and implement measures to mitigate the relevant risks.」
The Company has reaffirmed its structure for addressing natural disaster and infectious disease risks, under which the Risk Management Committee reviews them monthly and instructs the implementation of mitigation measures as necessary. - FY2021MitigatedAnnual report
「The Company has not been affected by the current spread of COVID-19. To prevent internal infections, it has worked to establish a telework environment, hold meetings online and refrain from business trips, while limiting attendance at the workplace to the extent necessary for business operations.」
The Company states that infectious diseases have had no impact on its business and has implemented measures including telework, web conferences, restrictions on business trips and PCR testing. - FY2021-Q3RestatedAnnual report
「The Company continues to monitor the impact of the spread of COVID-19 on business activities and results, but depending on how the infection situation develops, it may affect the Company’s results and financial position.」
The Company continues to monitor the impact of COVID-19 on business activities and results and has reaffirmed that future developments in the infection situation could affect results and financial position. It states that there have been no material changes to the risk item. quantified is false, materialized is false. - FY2021-Q2MaterialisedAnnual report
「The impact of COVID-19 was minor during the cumulative second quarter period, but infection-control measures, including the introduction of remote work and the postponement of transfers and business trips, disrupted some sales and research and development activities and the flexible reassignment of personnel. These effects are gradually being resolved as measures have been eased in line with infection trends and work efficiency has improved through the adoption of remote work and web conferences.」
The Company states that infectious diseases caused actual disruptions to sales, research and development, and personnel allocation, but that the impact is gradually being resolved through the adoption of remote work and web conferences. - FY2021-Q1SoftenedAnnual report
「The impact of the spread of COVID-19 on business activities and results is currently minor, but depending on how the infection situation develops, it may affect the Company’s results and financial position.」
The Company characterises the current impact of COVID-19 on business activities and results as minor, while maintaining that future developments in the infection situation could affect results and financial position. - FY2020First statedAnnual report
「If the Company’s or its customers’ buildings, facilities or employees are affected by a major earthquake, large typhoon, windstorm, flood, tsunami, heavy snowfall, fire or other disaster, attendance and business operations may be disrupted, potentially affecting the Company’s results and financial position. Similarly, if infectious diseases such as influenza or COVID-19 spread, employee attendance and business operations may be disrupted, potentially affecting the Company’s results and financial position.」
The Company identifies as new risks not only disruptions to business operations caused by natural disasters and infectious diseases, but also possible restraint of IT investment through economic conditions and customer performance, declines in new projects and reductions in existing projects. The main text also describes the impact of the global spread of COVID-19 on the global economy and financial markets, but does not indicate any specific impact on the Company.